NorthStrive Biosciences plans FACS study for EL-22 probiotic candidate
Go back to NorthStrive Biosciences plans FACS study for EL-22 probiotic candidate| (NASDAQ: ELAB) | Delayed: 1.02 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.02 | 52 Week High | $ | |||
| Open | $1.02 | 52 Week Low | $ | |||
| Day High | $1.02 | P/E | N/A | |||
| Day Low | $1.02 | EPS | $ | |||
| Volume | 53,910 | |||||
